MINNEAPOLIS--(BUSINESS WIRE)--Feb. 25, 2013-- DaVita Clinical Research® (DCR®), a specialty contract research organization with services spanning the full spectrum of drug and device...
DENVER--(BUSINESS WIRE)--Feb. 14, 2013-- DaVita HealthCare Partners Inc. (NYSE: DVA) today announced results for the quarter and year ended December 31, 2012. Adjusted net income attributable to...
DENVER--(BUSINESS WIRE)--Feb. 12, 2013-- DaVita, a division of DaVita HealthCare Partners Inc.(NYSE: DVA) and a leading provider of kidney care services, today issued important emergency response...
DENVER--(BUSINESS WIRE)--Jan. 29, 2013-- DaVita HealthCare Partners Inc. (NYSE: DVA) announced today that it will hold its quarterly conference call to discuss fourth quarter results onThursday,...
DENVER & TAIPEI, Taiwan--(BUSINESS WIRE)--Jan. 20, 2013-- DaVita®, the kidney care division ofDaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today...